Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Detection of monocyte chemoattractant protein-1 receptor expression in experimental atherosclerotic lesions: an autoradiographic study.

Ohtsuki K, Hayase M, Akashi K, Kopiwoda S, Strauss HW.

Circulation. 2001 Jul 10;104(2):203-8.

PMID:
11447087
2.

Radiolabeled annexin V imaging: diagnosis of allograft rejection in an experimental rodent model of liver transplantation.

Ogura Y, Krams SM, Martinez OM, Kopiwoda S, Higgins JP, Esquivel CO, Strauss HW, Tait JF, Blankenberg FG.

Radiology. 2000 Mar;214(3):795-800.

PMID:
10715048
3.

Technetium-99m HYNIC-annexin V: a potential radiopharmaceutical for the in-vivo detection of apoptosis.

Ohtsuki K, Akashi K, Aoka Y, Blankenberg FG, Kopiwoda S, Tait JF, Strauss HW.

Eur J Nucl Med. 1999 Oct;26(10):1251-8.

PMID:
10541822
4.

Imaging of apoptosis (programmed cell death) with 99mTc annexin V.

Blankenberg FG, Katsikis PD, Tait JF, Davis RE, Naumovski L, Ohtsuki K, Kopiwoda S, Abrams MJ, Strauss HW.

J Nucl Med. 1999 Jan;40(1):184-91.

5.

In vivo detection and imaging of phosphatidylserine expression during programmed cell death.

Blankenberg FG, Katsikis PD, Tait JF, Davis RE, Naumovski L, Ohtsuki K, Kopiwoda S, Abrams MJ, Darkes M, Robbins RC, Maecker HT, Strauss HW.

Proc Natl Acad Sci U S A. 1998 May 26;95(11):6349-54.

6.

Clinical decision making based on radionuclide determined ejection fraction in oncology patients.

Peng NJ, Advani R, Kopiwoda S, Fisher G, Strauss HW.

J Nucl Med. 1997 May;38(5):702-5.

7.

2-aminoethylphosphonic acid: biodistribution of a naturally occurring phosphonate after labelling with technetium-99m.

Castronovo FP, Kopiwoda S, Peterson M.

Nucl Med Commun. 1996 Oct;17(10):902-6.

PMID:
8951913
8.

Biodistribution of tantalum-178: a short-lived radiopharmaceutical for blood pool imaging.

Wilson RA, Kopiwoda SY, Callahan RJ, Moore RH, Boucher CA, Manspeaker H, Castronovo FP, Strauss HW.

Eur J Nucl Med. 1987;13(2):82-5.

PMID:
3609057
9.

Magnetic resonance imaging of the prostate.

Bryan PJ, Butler HE, Nelson AD, LiPuma JP, Kopiwoda SY, Resnick MI, Cohen AM, Haaga JR.

AJR Am J Roentgenol. 1986 Mar;146(3):543-8.

PMID:
2418665
10.

Abdominal neuroblastoma: magnetic resonance imaging and tissue characterization.

Fletcher BD, Kopiwoda SY, Strandjord SE, Nelson AD, Pickering SP.

Radiology. 1985 Jun;155(3):699-703.

PMID:
4001372
11.

Gated magnetic resonance imaging of the normal and diseased heart.

Lieberman JM, Alfidi RJ, Nelson AD, Botti RE, Moir TW, Haaga JR, Kopiwoda S, Miraldi FD, Cohen AM, Butler HE, et al.

Radiology. 1984 Aug;152(2):465-70.

PMID:
6739817
12.

The effect of motion on two-dimensional Fourier transformation magnetic resonance images.

Schultz CL, Alfidi RJ, Nelson AD, Kopiwoda SY, Clampitt ME.

Radiology. 1984 Jul;152(1):117-21.

PMID:
6729101
13.

A comparison of the technetium-labeled myocardial agents DiArs and DMPE to 201Tl in experimental animals.

Sullivan PJ, Werre J, Elmaleh DR, Okada RD, Kopiwoda SY, Castronovo FP Jr, McKusick KA, Strauss HW.

Int J Nucl Med Biol. 1984;11(1):3-10.

PMID:
6735606
14.

Selective accumulation of low density lipoproteins in damaged arterial wall.

Roberts AB, Lees AM, Lees RS, Strauss HW, Fallon JT, Taveras J, Kopiwoda S.

J Lipid Res. 1983 Sep;24(9):1160-7.

15.
16.

Myocardial imaging with 9-[Te-123m]telluraheptadecanoic acid.

Elmaleh DR, Knapp FF Jr, Yasuda T, Coffey JL, Kopiwoda S, Okada R, Strauss HW.

J Nucl Med. 1981 Nov;22(11):994-9.

17.
18.

Beta receptor occupancy. Assessment in the intact animal.

Homcy CJ, Strauss HW, Kopiwoda S.

J Clin Invest. 1980 May;65(5):1111-8.

19.

Biodistribution of 14C-lomustine in an animal tumor model.

Castronovo FP Jr, Potsaid MS, Kopiwoda SY.

J Pharm Sci. 1980 Jan;69(1):87-9.

PMID:
7354451

Supplemental Content

Loading ...
Support Center